Sort
48,018 grants matching “immunotherapy”
Tumor microenvironment-dependent therapy resistance
$407,872Shahab Asgharzadeh · Children'S Hosp Of Philadelphia · P01 · FY2025 · CA
Targeting evolving therapy resistance
$407,872Yael P Mosse · Children'S Hosp Of Philadelphia · P01 · FY2025 · CA
Targeting neuroblastoma cell state plasticity
$407,872Kimberly Stegmaier · Children'S Hosp Of Philadelphia · P01 · FY2025 · CA
Leveraging biological insights to enhance immunotherapies
$407,870Robbie G. Majzner · Children'S Hosp Of Philadelphia · P01 · FY2025 · CA
Translational, statistical, and clinical trials core
$407,869Julie R Park · Children'S Hosp Of Philadelphia · P01 · FY2025 · CA
NanoOptogenetic immunotherapy for B cell lymphoma
$407,858Gang Han · Univ Of Massachusetts Med Sch Worcester · R01 · FY2023 · CA
Imaging mitochondrial heterogeneity in LKB1 mutant lung cancer
$407,842David B Shackelford · University Of California Los Angeles · R01 · FY2024 · CA
ISG15 and Protein ISGylation in Cancer
$407,842Dong-Er Zhang · University Of California, San Diego · R01 · FY2022 · CA
Mutant BRAF as a Therapeutic Target for Melanoma
$407,790Dorothee M Herlyn · Wistar Institute · P01 · FY2009 · CA
MR Signal Amplification for Receptor Imaging
$407,779Alexei A Bogdanov · Univ Of Massachusetts Med Sch Worcester · R01 · FY2022 · EB
MR Signal Amplification for Receptor Imaging
$407,779Alexei A Bogdanov · Univ Of Massachusetts Med Sch Worcester · R01 · FY2020 · EB
MR Signal Amplification for Receptor Imaging
$407,779Alexei A Bogdanov · Univ Of Massachusetts Med Sch Worcester · R01 · FY2019 · EB
Project 2: Characterizing and overcoming failure to respond to PD-1 blockade therapy
$407,751Paul Nghiem · University Of Washington · P01 · FY2022 · CA
Matching genotypes with personalized therapies: Development of a decision support infrastructure to augment the value of precision medicine
$407,738Valsamo Anagnostou · Johns Hopkins University · U01 · FY2023 · CA
Matching genotypes with personalized therapies: Development of a decision support infrastructure to augment the value of precision medicine
$407,737Valsamo Anagnostou · Johns Hopkins University · U01 · FY2025 · CA
Evaluation New Targets of CMV Cellular Immunity
$407,717John A Zaia · Beckman Research Institute/City Of Hope · R01 · FY2007 · AI
Multiple Tumor Antigen-loaded DC Vaccine for Hepatocellular Cancer
$407,715Lisa Helene Butterfield · University Of Pittsburgh At Pittsburgh · R01 · FY2012 · CA
CHILDRENS CANCER GROUP
$407,710Children'S Hospital Of Philadelphia · U10 · FY2001 · CA
Investigation of T cell responses to immunotherapy using class II tetramers
$407,670William W. Kwok · Benaroya Research Inst At Virginia Mason · R01 · FY2012 · AI
IDO2 Targeting in Pancreatic Cancer
$407,668George C Prendergast · Lankenau Institute For Medical Research · R01 · FY2015 · CA
Improving response to immunotherapy by genistein and antiestrogens
$407,663Leena A Hilakivi-Clarke · University Of Minnesota · R21 · FY2021 · CA
Prediagnostic exposures, germline genetics, and triple negative breast cancer mutational and immune profiles
$407,658Rulla M Tamimi · Weill Medical Coll Of Cornell Univ · U01 · FY2024 · CA
Mechanism(s) of pathogenicity for Candida auris
$407,607Jeniel E Nett · University Of Wisconsin-Madison · R01 · FY2025 · AI
Multiple Approaches to Abeta Vaccination in Animal Models
$407,576David Hastings Cribbs · University Of California-Irvine · R01 · FY2008 · AG
Western Regional Community Clinical Oncology Program
$407,540Banner Good Samaritan Medical Center · U10 · FY2003 · CA